(Q54003338)
Statements
A phase I trial of hypoxoside as an oral prodrug for cancer therapy--absence of toxicity (English)
B J Smit
C F Albrecht
R W Liebenberg
P B Kruger
M Freestone
L Gouws
E Theron
P J Bouic
S Etsebeth
P P van Jaarsveld
1 September 1995